Jpmorgan Chase & Co »

Syros Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Syros Pharmaceuticals (SYRS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Syros Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syros Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syros Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.3k 549 7.79
2023-09-30 $4.3k 1.1k 3.95
2023-06-30 $1.9k 596 3.15
2023-03-31 $2.0k 596 3.36
2022-12-31 $2.0k 596 3.36